FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease. Released August 17, 2017

FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease. Released August 17, 2017

FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease. Released August 17, 2017

FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease

Experts from the U.S. Food and Drug Administration (FDA) discuss important new drug information as well as urgent insights about approved drug products.

Share FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease

Sign up to save your podcasts

FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease

FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease